共 50 条
- [42] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis? [J]. Nature Clinical Practice Rheumatology, 2006, 2 : 400 - 401
- [43] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis? [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 400 - 401
- [44] Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis [J]. BMC Musculoskeletal Disorders, 8
- [46] High Titer IgG Anti-Cyclic Citrullinated Peptide Antibodies Are Associated With Joint Destruction In Juvenile Idiopathic Arthritis Patients [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S936 - S936
- [47] Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis (jia). A monocentric cross-sectional study. [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S84 - S84
- [49] Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients [J]. Clinical Rheumatology, 2016, 35 : 601 - 607
- [50] Diagnostic Utility of AxSYM Anti-Cyclic Citrullinated Peptide Antibody Assay [J]. KOREAN JOURNAL OF LABORATORY MEDICINE, 2008, 28 (06): : 457 - 464